Clinical Trial

The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy

Study acronym: HYPIC
Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
Evaluating the long-term therapeutic effects and safety of hydroxychloroquine(compared to glucocorticoid therapy alone) in patients with inflammatory cardiomyopathy--a multicenter randomized controlled study
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-07-18; most recent amendment 2024-10-06.
Trial Details
NCT Number NCT05961202
Lead Sponsor Tongji Hospital
Collaborators: Wuhan Central Hospital, Taihe Hospital
Conditions Inflammatory Cardiomyopathy, Myocarditis
Enrollment 200 participants
Start Date 2021-11-01
Primary Completion 2024-09-01 (estimated)
Study Completion 2025-11-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-09